Edward P. Vacek

427 total citations
11 papers, 256 citations indexed

About

Edward P. Vacek is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Edward P. Vacek has authored 11 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Edward P. Vacek's work include Chemical Synthesis and Analysis (3 papers), Synthesis of Tetrazole Derivatives (2 papers) and Receptor Mechanisms and Signaling (2 papers). Edward P. Vacek is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Synthesis of Tetrazole Derivatives (2 papers) and Receptor Mechanisms and Signaling (2 papers). Edward P. Vacek collaborates with scholars based in United States, Germany and Singapore. Edward P. Vacek's co-authors include Peter R Bernstein, Frederick J. Brown, David W. Snyder, Ying K. Yee, Robert D. Krell, Bruce Gomes, Joseph C. Williams, Thomas Maduskuie, David Aharony and Robert T. Jacobs and has published in prestigious journals such as Journal of Medicinal Chemistry, Synthesis and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Edward P. Vacek

10 papers receiving 240 citations

Peers

Edward P. Vacek
Frederick J. Brown United States
Allen W. Harrison United States
Gary B. Steelman United States
David L. Musso United States
John W. Butcher United States
R. Tonani Italy
Lan Trinh United States
Frederick J. Brown United States
Edward P. Vacek
Citations per year, relative to Edward P. Vacek Edward P. Vacek (= 1×) peers Frederick J. Brown

Countries citing papers authored by Edward P. Vacek

Since Specialization
Citations

This map shows the geographic impact of Edward P. Vacek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward P. Vacek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward P. Vacek more than expected).

Fields of papers citing papers by Edward P. Vacek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward P. Vacek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward P. Vacek. The network helps show where Edward P. Vacek may publish in the future.

Co-authorship network of co-authors of Edward P. Vacek

This figure shows the co-authorship network connecting the top 25 collaborators of Edward P. Vacek. A scholar is included among the top collaborators of Edward P. Vacek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward P. Vacek. Edward P. Vacek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Veale, Chris A., David Aharony, Debra L. Banville, et al.. (2000). The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. part 1. Bioorganic & Medicinal Chemistry Letters. 10(17). 1949–1952. 28 indexed citations
2.
Bernstein, Peter R, et al.. (1995). Nonpeptidic Inhibitors of Human Leukocyte Elastase. 6. Design of a Potent, Intratracheally Active, Pyridone-Based Trifluoromethyl Ketone. Journal of Medicinal Chemistry. 38(1). 212–215. 37 indexed citations
4.
Bernstein, Peter R, et al.. (1994). Examination of peptidic α′,β-diamino-α,α-difluoroketones as inhibitors of human leukocyte elastase. Bioorganic & Medicinal Chemistry Letters. 4(18). 2175–2178. 9 indexed citations
5.
Matassa, Victor G., Peter R Bernstein, Howard Shapiro, et al.. (1991). ChemInform Abstract: Synthesis and in vitro LTD4 Antagonist Activity of Bicyclic and Monocyclic Cyclopentylurethane and Cyclopentylacetamide N‐ Arylsulfonylamides.. ChemInform. 22(8). 1 indexed citations
6.
Matassa, Victor G., Peter R Bernstein, Howard Shapiro, et al.. (1990). Synthesis and in vitro LTD4 antagonist activity of bicyclic and monocyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amides. Journal of Medicinal Chemistry. 33(9). 2621–2629. 16 indexed citations
7.
Yee, Ying K., Peter R Bernstein, Frederick J. Brown, et al.. (1990). A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles. Journal of Medicinal Chemistry. 33(9). 2437–2451. 50 indexed citations
8.
Brown, Frederick J., et al.. (1989). Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes. Journal of Medicinal Chemistry. 32(4). 807–826. 33 indexed citations
9.
Bernstein, Peter R, et al.. (1988). Synthesis and pharmacological characterization of a series of leukotriene analogs with antagonist and agonist activities. Journal of Medicinal Chemistry. 31(3). 692–696. 7 indexed citations
10.
Bernstein, Peter R & Edward P. Vacek. (1987). Improved Conditions for the Formation of Tetrazoles. Synthesis. 1987(12). 1133–1134. 36 indexed citations
11.
Bernstein, Peter R, et al.. (1986). Chemically stable homocinnamyl analogs of the leukotrienes: synthesis and preliminary biological evaluation. Journal of Medicinal Chemistry. 29(12). 2477–2483. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026